Evidence map›Paper›PMID 40681150›Full record

ArticleNew biotechnology2025

Conditional guide RNA deactivation by mRNA and small molecule triggers in Saccharomyces cerevisiae.

Chenggang Xi, Stephen Chiu, William E Voje, James M Carothers, Tae Seok Moon

Abstract read
In one paragraph

Article in New biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chenggang XiDepartment of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, St. Louis, MO 63130, United States.
Stephen ChiuDepartment of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, St. Louis, MO 63130, United States; Synthetic Biology Group, J. Craig Venter Institute, La Jolla, CA 92037, United States.
William E VojeDepartment of Chemical Engineering, University of Washington, Seattle, WA 98195, United States.
James M CarothersDepartment of Chemical Engineering, University of Washington, Seattle, WA 98195, United States; Molecular Engineering & Sciences Institute, University of Washington, Seattle, WA 98195, United States; Center for Synthetic Biology, University of Washington, Seattle, WA 98195, United States. Electronic address: jcaroth@uw.edu.
Tae Seok MoonDepartment of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, St. Louis, MO 63130, United States; Synthetic Biology Group, J. Craig Venter Institute, La Jolla, CA 92037, United States. Electronic address: tsmoon7@gmail.com.

Funding

Tunable therapeutic modulation of the gut microbiome by engineered probioticsR01AT009741 · NCCIH · WASHINGTON UNIVERSITY · PI DANTAS, GAUTAM, MOON, TAE SEOK · 2018 to 2022
$3.5M
NCCIH NIH HHS R01 AT009741
6 · The paper itself

Abstract

CRISPR interference (CRISPRi) technologies have revolutionized bioengineering by providing precise tools for gene expression modulation, enabling targeted gene perturbation and metabolic pathway optimization. Despite these advances, achieving dynamic control over gene expression by CRISPR-based regulation remains a challenge due to its inherently static nature. Utilizing toehold-mediated strand displacement and ligand-responsive ribozymes (aptazymes), this study introduces switchable guide RNAs (gRNAs) that facilitate tunable gene expression mediated by mRNA or small molecule signals. We demonstrate complete silencing of gRNA via strategically designed 5' or 3' extensions that impede the gRNA spacer or the dCas9 handle, with subsequent restoration of function through sequestration or cleavage of the obstructive sequence. The resulting toehold-embedded or aptazyme-embedded gRNAs can be deactivated by specific signals, including two full-length translatable mRNAs and two small molecule triggers, thereby lifting CRISPRi repression on targeted genes. This modular approach allows for gRNA-based biocomputing through multi-layer or multi-input genetic logic gates in Saccharomyces cerevisiae. Offering a versatile strategy for post-CRISPR regulation in response to environmental signals or cellular states, this methodology expands the toolkit in eukaryotic systems for reversible control of gene expression.

Indexed as

RNA, Guide, CRISPR-Cas SystemsRNA, MessengerSaccharomyces cerevisiaeCRISPR-Cas SystemsGene Expression Regulation, FungalRNA, Guide, CRISPR-Cas SystemsRNA, MessengerAptazymeCRISPRiGenetically encoded biosensorGuide RNA switchmRNA detectionToehold-mediated strand displacement

Identifiers

PMID40681150
PMCPMC12332140

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.